Clinical Evaluation of the Use of an mHealth Intervention on Quality of Care

Sponsor
World Vision Canada (Other)
Overall Status
Completed
CT.gov ID
NCT03874143
Collaborator
World Health Organization (Other), Ministry of Public Health Niger (Other), Ryerson University (Other), Global Affairs Canada (Other)
520
2
7

Study Details

Study Description

Brief Summary

Under the World Health Organization's (WHO) integrated community case management (iCCM) Rapid Access Expansion Program (RAcE), World Vision Niger and Canada supported the Niger Ministry of Public Health to implement iCCM in four health districts in Niger in 2013. Community health workers (CHWs), known as Relais Communautaire (RCom), were deployed in their communities to diagnose and treat children under five years of age presenting with diarrhea, malaria and pneumonia and refer children with severe illness to the higher-level facilities. Two of the districts piloted RCom using smartphones equipped with an application to support quality case management and provide good timely clinical data. A two-arm cluster randomized trial assessed the impact of use of the mHealth application mainly on quality of care (QoC), but also on motivation, retention and supervision

Condition or Disease Intervention/Treatment Phase
  • Other: mHealth Intervention for Quality of Care
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
520 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Clinical Evaluation of the Use of an mHealth Intervention on Quality of Care Provided by Community Health Workers in Southwest Niger
Actual Study Start Date :
Mar 1, 2016
Actual Primary Completion Date :
Oct 1, 2016
Actual Study Completion Date :
Oct 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: RCom equipped with a smartphone

Other: mHealth Intervention for Quality of Care
Does use of a specially equipped smartphone make a difference in the diagnosis and treatment by RCom of malaria, pneumonia and diarrhea in children aged 2 to 59 months

No Intervention: RCom with paper-based system

Outcome Measures

Primary Outcome Measures

  1. Quality of Care (QoC) provided by RCom [30 weeks]

    The maximum QoC score was 31 points; the score was weighted with two-thirds of the score allocated to screening questions and correct identification of the danger signs and signs/symptoms of serious conditions A perfect score was achieved when RComs asked all 10 health screening questions and correctly classified 4 major danger signs and 6 serious symptoms, made appropriate referral, and provided advice to caregivers.

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Months to 59 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • children presenting symptoms of illness
Exclusion Criteria:

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • World Vision Canada
  • World Health Organization
  • Ministry of Public Health Niger
  • Ryerson University
  • Global Affairs Canada

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
World Vision Canada
ClinicalTrials.gov Identifier:
NCT03874143
Other Study ID Numbers:
  • 001
First Posted:
Mar 14, 2019
Last Update Posted:
Mar 14, 2019
Last Verified:
Mar 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 14, 2019